ESC 365 - Should metastatic cancer be a contraindication to cardiac surgery? successful quadruple valve replacement in carcinoid heart disease presenting with hypoxia

ESC2025 Premium Access

Should metastatic cancer be a contraindication to cardiac surgery? successful quadruple valve replacement in carcinoid heart disease presenting with hypoxia

Session: Valve heart disease: surgical management and miscellaneous

Topic: Clinical

Speaker: Doctor M. Zgheib (Reading, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Michelle Zgheib

Royal Berkshire Hospital, Reading (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

4 more presentations in this session

Aggravated secondary mitral regurgitation after closure of a Giant Atrial Septal Artery Aneurysm originating from the left main coronary artery.

Speaker: Doctor Y. Huang (Changsha, CN)

Sudden, severe mitral regurgitation secondary to a ruptured chordae in a young patient with unknown rheumatic heart disease

Speaker: Doctor M. Jagiello (Waterford, IE)

A rare case of late-presenting traumatic aortic valve avulsion five years after a motorcycle crash: an old secret unveiled.

Speaker: Doctor S. Panthong (Bangkok, TH)

Event free survival of Chitra mechanical aortic valve without anticoagulation for 12 years

Speaker: Doctor D. Choudhary (Bikaner, IN)

Access the full session

Valve heart disease: surgical management and miscellaneous

Speakers: Doctor M. Zgheib, Doctor Y. Huang, Doctor M. Jagiello, Doctor S. Panthong, Doctor D. Choudhary

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources